CD46 Null Packaging Cell Line Improves Measles Lentiviral Vector Production and Gene Delivery to Hematopoietic Stem and Progenitor Cells

Authors:

Abstract
No abstract available
Funding Information
  • National Institutes of Health (2U54GM103368, 2P30AI036214, 1R01HL116221)